Intraocular pressure and optical coherence tomography concerning visual field outcomes in "green" patients: An observational study
Jia-Ying Chou,Po-Chen Tseng,Hsiao-Yun Hu,Chu-Yu Yen
DOI: https://doi.org/10.1097/md.0000000000040518
IF: 1.6
2024-11-28
Medicine
Abstract:Glaucoma is a clinically significant condition and a major public health concern due to its potential to cause irreversible blindness if left untreated. It is the second leading cause of blindness worldwide, primarily driven by the progressive degeneration of the optic nerve, which leads to visual field (VF) defects. [ 1 , 2 ] In 2020, the global age-adjusted prevalence of primary open-angle glaucoma (POAG) among individuals aged 40 and older was estimated at 2.22%, affecting approximately 63.44 million people. In East and Southeast Asia, the prevalence of POAG is projected to rise from 2.38% in 2020 to 4.09% by 2060, representing a 71.85% increase and an additional 30.77 million cases. [ 3 ] Glaucoma has a profound societal impact, placing significant burdens on patients, families, and healthcare systems. Huang et al [ 4 ] reported that glaucoma adversely affects social function, mental health, and daily activities. Patients with advanced disease also experience reduced physical activity, which correlates with declines in both social function and mental health. Economically, the costs of long-term glaucoma management—including diagnostic tests, medications, surgeries, and rehabilitation—are considerable, particularly in low- and middle-income countries, where resources for screening and treatment are often limited. Studies show that low-income earners may spend as much as 26.08% of their monthly income on glaucoma treatment, while middle-income earners spend 5.17%. [ 5 ] Beyond financial strain, glaucoma places a heavy emotional and psychological burden on patients, stemming from the fear of vision loss and the need for lifelong treatment. [ 6 ] Given the increasing prevalence of glaucoma and its profound personal and societal impacts, research is urgently needed to improve early detection, treatment options, and long-term management strategies. Glaucoma diagnosis is based on several key criteria. [ 7 ] Elevated intraocular pressure (IOP), or ocular hypertension (OHT), is a critical indicator, as increased IOP can damage the optic nerve by causing compression, reduced blood flow, and impaired axonal transport, leading to the loss of retinal ganglion cells. [ 8 ] Structural changes, such as retinal nerve fiber layer (RNFL) thinning, optic disc cupping, and ganglion cell loss, often precede VF loss, meaning significant damage may occur before the patient experiences noticeable symptoms. [ 9 ] VF defects, such as peripheral vision loss, are essential markers of functional impairment and critical for assessing glaucoma's impact on daily life. [ 10 ] Because structural damage often precedes detectable VF loss, both structural and functional assessments are vital for early and accurate diagnosis. Optical coherence tomography (OCT) is an indispensable tool in glaucoma management. It provides high-resolution, cross-sectional imaging of the optic nerve and retinal structures. Technological advancements, such as spectral-domain OCT (SD-OCT) and swept-source OCT, have improved diagnostic capabilities by enhancing image resolution and acquisition speed. [ 11 ] These innovations enable more precise measurements of parameters such as disc area, rim area, cup-to-disc (C/D) ratio, and RNFL thickness. The improved imaging quality allows for earlier detection of glaucomatous changes and clearer differentiation between glaucomatous and nonglaucomatous eyes. [ 12 ] Furthermore, OCT is invaluable for tracking disease progression, making it an essential tool for both diagnosis and long-term management. [ 13 ] However, a subset of glaucoma patients, referred to as having "green disease," presents a diagnostic challenge. These patients show normal OCT parameters, such as RNFL thickness and optic nerve head (ONH) structure, yet still exhibit VF abnormalities. [ 14 , 15 ] Several potential mechanisms may explain this discrepancy. Early retinal ganglion cell damage may affect visual function before significant structural changes are detectable by OCT. [ 16 ] Additionally, microvascular dysfunction or damage to deeper retinal layers, which current OCT technology may not easily capture, could contribute to VF loss. [ 17 ] This underscores the limitations of relying solely on OCT for diagnosing and monitoring glaucoma.
medicine, general & internal